SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma
Clinical trial NCT07668570 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07668570
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2029-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.